Cassady Schiller Wealth Management, LLC Denali Therapeutics Inc. Transaction History
Cassady Schiller Wealth Management, LLC
- $268 Million
- Q4 2024
A detailed history of Cassady Schiller Wealth Management, LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Cassady Schiller Wealth Management, LLC holds 18 shares of DNLI stock, worth $375. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18Holding current value
$375% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DNLI
# of Institutions
236Shares Held
120MCall Options Held
60.6KPut Options Held
48.4K-
Black Rock Inc. New York, NY13.2MShares$275 Million0.01% of portfolio
-
Baillie Gifford & CO12.3MShares$257 Million0.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$251 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA10.7MShares$224 Million0.06% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.91MShares$165 Million0.05% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $2.8B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...